ART4 and COVID-19: Through single-cell sorting of S-glycoprotein-specific memory B cells from COVID-19 convalescent individuals, 453 NAbs were identified, the most potent of which could neutralize the virus at very low doses, exhibiting significant prophylactic and therapeutic efficacy in a hamster COVID-19 model [13].